US 10478430
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
granted A61KA61K31/496A61K31/4965
Quick answer
US patent 10478430 (Compounds useful as inhibitors of ATR kinase and combination therapies thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/496, A61K31/4965, A61K31/497, A61K31/55